Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone long-term safety in opioid-induced bowel dysfunction
NCT00620061Phase 3Completed
- Sponsor
- Sucampo
- Start
- Dec 2007
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of cobiprostone in opioid-induced bowel dysfunction (OIBD), sponsored by Sucampo. Started Dec 2007; status: completed.
02
Drugs
cobiprostone
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on NCT00620061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620061.